article thumbnail

BMF Biotechnology Launches 3D Printed Organ-On-A-Chip Platform to Accelerate Life Sciences Research

HIT Consultant

What You Should Know; – Boston Micro Fabrication (BMF) today announced the launch of BMF Biotechnology Inc., Expanding Beyond Printing: The Rise of BMF Biotechnology In late 2022, BMF embarked on a strategic expansion. The initial phase of research has yielded highly promising results.

article thumbnail

Phenomix Sciences, InformedDNA Integrate to Advance Genetics-Driven Obesity Care

HIT Consultant

What You Should Know: – Phenomix Sciences , a precision medicine biotechnology company that brings data intelligence to the treatment of obesity, announces a new partnership to advance precision medicine in obesity with InformedDNA, the nation’s leading applied genomics solutions company.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

NVentures Invests in Genesis Therapeutics’ AI Platform for Drug Development

HIT Consultant

Genesis Therapeutics Partners with NVIDIA to Advance AI-Driven Drug Discovery Genesis Therapeutics, an AI-focused biotechnology company headquartered in Burlingame, CA, is revolutionizing small molecule drug discovery through its proprietary generative and predictive AI platform, **GEMS (Genesis Exploration of Molecular Space)**.

article thumbnail

Day 3 HIMSS Roundup: Glooko Acquires DIABNEXT, GE Healthcare/AliveCor Integration

HIT Consultant

Together PointClickCare and Audacious Inquiry will improve patient outcomes through a highly integrated care collaboration platform, powered by the largest network of its kind in North America. GE Healthcare and AliveCor Integrating Data from Consumer ECGs Into Clinical Workflow. RevSpring Expands Integrations with Cerner.

article thumbnail

Glooko Secures $100M, Appoints Mike Alvarez as New CEO

HIT Consultant

Device Integrations: Expanding the platform’s compatibility with various medical devices and wearables to streamline data collection and improve patient monitoring. Clinical Research: Supporting clinical trials and research initiatives through the platform’s robust data management and analytics capabilities.

article thumbnail

Accenture Invests in 1910 Genetics to Accelerate AI-Powered Drug Discovery

HIT Consultant

What You Should Know: – Accenture has made a strategic investment, through Accenture Ventures , in 1910 Genetics , a biotechnology company revolutionizing drug discovery with its AI-powered platform. Terms of the investment were not disclosed.

article thumbnail

Quantiphi Invests in Transcell to Advance AI-Driven Drug Discovery

HIT Consultant

This collaboration marks a significant step forward in the integration of AI and biotechnology for drug discovery and development. What You Should Know: – Quantiphi , an AI-first digital engineering company, announced a strategic minority investment in Transcell , a pioneering stem cell-based biotech innovator.